View Item 

Show simple item record

Bioequivalence of Topical Dermatological Dosage Forms-Methods of Evaluation of Bioequivalence

dc.contributor.authorShah, Vinod P.en_US
dc.contributor.authorBon, Charlesen_US
dc.contributor.authorKaplan, Stanley A.en_US
dc.contributor.authorYacobi, Avrahamen_US
dc.contributor.authorMaibach, Howard I.en_US
dc.contributor.authorFleischer, Nicholas M.en_US
dc.contributor.authorFranz, Thomas J.en_US
dc.contributor.authorKawamoto, Jeffen_US
dc.contributor.authorMarty, Jean-Paulen_US
dc.contributor.authorLesko, Lawrence J.en_US
dc.contributor.authorWilkin, Jonathanen_US
dc.contributor.authorPershing, Lynn K.en_US
dc.contributor.authorSchaefer, Hansen_US
dc.contributor.authorSequeira, Joel A.en_US
dc.contributor.authorShrivastava, Surendra P.en_US
dc.contributor.authorWilliams, Roger L.en_US
dc.contributor.authorFlynn, Gordon L.en_US
dc.date.accessioned2006-09-08T19:17:08Z
dc.date.available2006-09-08T19:17:08Z
dc.date.issued1998-02en_US
dc.identifier.citationShah, Vinod P.; Flynn, Gordon L.; Yacobi, Avraham; Maibach, Howard I.; Bon, Charles; Fleischer, Nicholas M.; Franz, Thomas J.; Kaplan, Stanley A.; Kawamoto, Jeff; Lesko, Lawrence J.; Marty, Jean-Paul; Pershing, Lynn K.; Schaefer, Hans; Sequeira, Joel A.; Shrivastava, Surendra P.; Wilkin, Jonathan; Williams, Roger L.; (1998). "Bioequivalence of Topical Dermatological Dosage Forms-Methods of Evaluation of Bioequivalence." Pharmaceutical Research 15(2): 167-171. <http://hdl.handle.net/2027.42/41463>en_US
dc.identifier.issn0724-8741en_US
dc.identifier.issn1573-904Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/41463
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=9523299&dopt=citationen_US
dc.format.extent487225 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherBiochemistry, Generalen_US
dc.subject.otherPharmacyen_US
dc.subject.otherBiomedical Engineeringen_US
dc.subject.otherMedical Lawen_US
dc.titleBioequivalence of Topical Dermatological Dosage Forms-Methods of Evaluation of Bioequivalenceen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumSchool of Pharmacy, University of Michigan, Ann Arbor, Michigan, 48109en_US
dc.contributor.affiliationotherDepartment of Dermatology, University of California Medical Center, San Francisco, California, 94143en_US
dc.contributor.affiliationotherDepartment of Dermatology, University of Utah, Salt Lake City, Utah, 84132en_US
dc.contributor.affiliationotherOffice of Pharmaceutical Science, CDER, FDA, Rockville, Maryland, 20857en_US
dc.contributor.affiliationotherL'Oreal, Clichy Cedex, Franceen_US
dc.contributor.affiliationotherDivision of Bioequivalence, Office of Generic Drugs, OPS, CDER, FDA, Rockville, Maryland, 20855en_US
dc.contributor.affiliationotherOffice of Pharmaceutical Science, CDER, FDA, Rockville, Maryland, 20857en_US
dc.contributor.affiliationotherUniversity of Paris, Chatenay-Malabry, Franceen_US
dc.contributor.affiliationotherOffice of Clinical Pharmacology and Biopharmaceutics, OPS, CDER, FDA, Rockville, Maryland, 20857en_US
dc.contributor.affiliationotherHealth Protection Branch, Ottowa, Ontario, Canada, KIA-IB6en_US
dc.contributor.affiliationotherAlpharma, Inc., Baltimore, Maryland, 21224en_US
dc.contributor.affiliationotherNovum Pharmaceuticals, Pittsburgh, PA, 15206en_US
dc.contributor.affiliationotherSchering-Plough Research Institute, Kenilworth, New Jersey, 07033en_US
dc.contributor.affiliationotherDivision of Dermatology and Dental Products, Office of Drug Evaluation, CDER, FDA, Rockville, Maryland, 20855en_US
dc.contributor.affiliationotherTaro Pharmaceutical, Inc., Hawthorne, New York, 10532en_US
dc.contributor.affiliationotherDivision of Bioequivalence, Office of Generic Drugs, OPS, CDER, FDA, USAen_US
dc.contributor.affiliationotherDepartment of Dermatology, University of Arkansas, Little Rock, Arkansas, 72205en_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid9523299en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/41463/1/11095_2004_Article_303794.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1023/A:1011941929495en_US
dc.identifier.sourcePharmaceutical Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
11095_2004_Article_303794.pdf
Size:
475.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.